Atlas Trials

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-G3031 in Healthy Subjects

Clinical trial NCT02342041 · COMPLETED

Trial details

NCT number
NCT02342041
Sponsor
Suven Life Sciences Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cognitive Disorders
Start date
2014-09-01
Primary completion
2015-06-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.